Abstract: The present invention relates to a novel pharmaceutical composition of Tamsulosin and Dutasteride and process of manufacture thereof. Specifically, the present invention relates to multiparticulate(s) of Tamsulosin and Dutasteride filled in capsule or/compressed in tablet dosage form and process of manufacture thereof.

Abstract: This invention discloses an orodispersible thin film for providing a substrate for printing of at least one Active ingredient on its surface that remains free from cavities after printing, method making the film, the substrate for the printing and a hydrophobic edible ink comprising at least one Active Ingredient for the printing. The Invention includes all films having orodispersibility property; including rectal, vaginal, ocular film and any other film meant for oral or transmucosal delivery. One or more of ingredient/s that make the substrate of this invention act as adsorbents and impart/s required roughness to the surface of the substrate. The ink does not crystallize on drying and remains stable at least for six months at 40° C. and 75% RH; and is printable using a Continuous Inkjet printer.

Abstract: This invention comprises a water free liquid composition comprising Teriparatide for transmucosal delivery that adheres to mucosa after coming in contact with mucosal surface and a system of making dosage form from the same and delivering to mucous membrane at various locations though liquid drops, capsule or tablets. The liquid composition is characterized by being a monophasic composition. The liquid monophasic composition comprises a non-aqueous liquid as carrier, a penetration enhancer/permeation enhancer, stabilizer and a surfactant. The liquid composition of Teriparatide intended to be dispensed to a mucosal membrane of oral/buccal cavity as liquid drops, or of oral/buccal cavity or nasal cavity as an oral or nasal spray or of oral/buccal cavity as an oral film; or of a part of alimentary canal as incorporated in a capsule or a tablet as an ingredient.

Abstract: The present invention relates to a novel pharmaceutical composition of Tamsulosin and Dutasteride and process of manufacture thereof. Specifically, the present invention relates to multiparticulate(s) of Tamsulosin and Dutasteride filled in capsule or/compressed in tablet dosage form and process of manufacture thereof.

Abstract: The invention comprises a ready to use film dosage form comprising microemulsion of an Active Pharmaceutical Ingredient embedded or immobilized in a thin polymeric matrix as a double microemulsion and a process of making the same. The microemulsion in the film dosage form of this invention is capable of being absorbed through mucosal route. The process of making the film dosage of this invention comprises steps of forming a film forming dispersion containing film forming polymers, excipients and microemulsion of active pharmaceutical ingredient, casting the same in the form of a film and drying the cast of the film being carried out by means of drying conditions that suit to retain stability of the active pharmaceutical ingredient being selected such that drying of the film is achieved retaining the moisture trapped in the microemulsion embedded in the polymeric film.

Abstract: This invention comprises a method of transmucosal delivery of process of Vitamin B12 without the need of intrinsic factor comprising administering a solid composition comprising a Vitamin B12 and at least one bifunctional macromolecule with hydrophilic exterior and with hydrophobic pockets capable of pocketing Vitamin B12 material, illustrated by cyclodextrin, at least one permeation enhancer, illustrated by Isopropyl Myristate and at least one agent that is mucoadhessive as well as penetration enhancer, illustrated by chitosan. The solid composition of Vitamin B12 of claim 2 may comprise a lozenge, a candy, a wafer, a tablet, a patch, a film, a spray, a lip balm, or gum.

Abstract: The invention comprises a ready to use film dosage form comprising microemulsion of an Active Pharmaceutical Ingredient embedded or immobilized in a thin polymeric matrix as a double microemulsion and a process of making the same. The microemulsion in the film dosage form of this invention is capable of being absorbed through mucosal route. The process of making the film dosage of this invention comprises steps of forming a film forming dispersion containing film forming polymers, excipients and microemulsion of active pharmaceutical ingredient, casting the same in the form of a film and drying the cast of the film being carried out by means of drying conditions that suit to retain stability of the active pharmaceutical ingredient being selected such that drying of the film is achieved retaining the moisture trapped in the microemulsion embedded in the polymeric film.